AML Global Portal | Quarter Four 2019 Update

The AML Global Portal (AGP) continues to disseminate the latest clinical updates in acute myeloid leukemia (AML), including diagnosis, prophylaxis, and treatment options.

Last quarter, the AGP Steering Committee were proud to host a meeting, comprised of international world experts in AML, in Estoril, PT. The AGP is a global online resource that provides vital information for treatment teams, including hematologists and oncologists, with an ever-expanding social media presence. The AGP engages with the global community on all major social media networks, providing a finger on the pulse of everyday, real-world clinical practice.

The AGP is designed to deliver upon an unmet need for targeted medical updates, to help treatment teams involved in AML care make informed therapeutic decisions. Last quarter, the AGP introduced new monthly editorial themes. Themes included: the role of measurable residual disease to guide treatment decisions, the use of transplantation in the treatment landscape of AML, and maintenance therapy. These themes were infused with the latest clinical and translational insights gathered during conference attendance at the 61st American Society of Hematology Annual Meeting & Exposition, Orlando, US, and the 5th International Conference on AML “Molecular and Translational”: Advances in Biology and Treatment, Estoril, PT.

The AGP is facilitated by Scientific Education Support (SES), who love nothing more than building communities and networks to enhance the level of collective knowledge, using multichannel communications to disseminate medical advances.

The AGP would like to thank our silver supporters, Amgen, AbbVie, Roche, Genentech, Daiichi–Sankyo, and Novartis; bronze supporters, Celgene, Janssen Oncology, Jazz Pharmaceuticals, and Pfizer; contributors, Agios and Helsinn, for their continued support of the initiative.

For more information on the AGP, please visit: For media enquiries or to explore collaboration opportunities, please contact:

Press release distributed by Pressat on behalf of Scientific Education Support, on Friday 17 January, 2020. For more information subscribe and follow

AML Acute Myeloid Leukemia Cancer Hematology Medical & Pharmaceutical
Published By

Scientific Education Support
Visit Newsroom


No media attached. Please contact Scientific Education Support for more information.

Additional PR Formats

You just read:

AML Global Portal | Quarter Four 2019 Update